According to research at the Society for Endocrinology annual conference in Brighton, the cure to a destructive form of breast cancer has been identified. This study tells that exposure to daily life commodities can lead to the development of breast cancer, it also put forward some suggestion of treatment
Triple-negative breast cancer (TNBC) is an aggressive particularly affects the younger people but is still curable if caught early. TNBC is resistant to hormone treatments that are used to treat other types of breast cancer. TNBC is, therefore, treated with either surgery or radiotherapy. It is important for us to understand TNBC biologically to develop new cures for this disease and also to improve the living standards of people already suffering through.
A study led by Dr. Laura Matthews and Professor Chris Twelves mapped all the Nuclear Receptors (NR) available taken from different types of breast cancer and from the normal breast tissue and identified common variations in the activity of the cells. Then the results are compared with other studies to identify NRs associated specifically with TNBC. This made the identification of drugs possible that which drugs caused NR Profiles for TNBC, these drugs were of different genres some were insecticides and pesticides, they also included many other daily life chemicals used around us.
According to a researcher to identify NR networks we need to investigate how environmental chemicals can cause mutation of cells and lead to the development of breast cancer. It is also being tested whether using drug combinations that target multiple NRs can prevent or be an effective treatment for TNBC. The research and all the study is determined for the noble cause of helping the patients out, making their life easy and helping people understand that how can the growth of breast cancer can be reduced and that cancer is fully curable if caught in early stages.